{"id":"W2151979638","doi":"10.1634/theoncologist.10-5-345","title":"HER1/EGFR Inhibitor-Associated Rash: Future Directions for Management and Investigation Outcomes from the HER1/EGFR Inhibitor Rash Management Forum","year":2005,"lang":"en","type":"review","venue":"The Oncologist","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":275,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Notre-Dame","funders":"National Cancer Institute; Genentech; F. Hoffmann-La Roche","keywords":"Rash; Medicine; Dermatology; Acne; EGFR inhibitors; Adverse effect; Etiology; Epidermal growth factor receptor; Pathology; Internal medicine; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01181177,0.0006815272,0.00117344,0.001895299,0.00146057,0.004251596,0.001445638,0.003104002,0.03582477],"category_scores_gemma":[0.03664202,0.0002681963,0.002166991,0.001341184,0.0006488127,0.005587744,0.003231065,0.005174202,0.006467137],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002555605,"about_ca_system_score_gemma":0.007034408,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003102523,"about_ca_topic_score_gemma":0.006163697,"domain_scores_codex":[0.9963187,0.001472266,0.0003968102,0.0001768423,0.00105986,0.0005754303],"domain_scores_gemma":[0.9625424,0.008081742,0.002943696,0.0007698667,0.01462297,0.01103939],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003560042,0.0004224794,0.0132695,0.001597038,0.00004518508,0.0002774334,0.0001747519,0.0002481892,0.000110548,0.002134702,0.4993369,0.4820273],"study_design_scores_gemma":[0.0007392232,0.001499204,0.05603364,0.02247491,0.0004883268,0.00223189,0.003382989,0.00217131,0.0004172101,0.02360029,0.886731,0.000229889],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.01350021,0.1555303,0.007363035,0.7403177,0.02911646,0.0008176373,0.003428553,0.001035058,0.04889118],"genre_scores_gemma":[0.1576794,0.3784462,0.05650752,0.2382395,0.09181954,0.003446581,0.01825493,0.0007566652,0.05484966],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03582477,"threshold_uncertainty_score":0.1198458,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06765387642643766,"score_gpt":0.3690442441056063,"score_spread":0.3013903676791686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}